NTI 15.5% 4.9¢ neurotech international limited

If the next trial has the same success as the first and FDA...

  1. 593 Posts.
    lightbulb Created with Sketch. 120
    If the next trial has the same success as the first and FDA approval is granted.....this could be a life changing stock....not just for us shareholders but the families with ASD kids. To have your son or daughter be brought back into mainstream classes and being brought into more normal relationships must be a dream come true for parents and the kids.

    I hope NTI164 can be a success for all involved.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.